SlideShare uma empresa Scribd logo
1 de 11
Baixar para ler offline
WE ARE HETERO,




 a research-based, global pharmaceutical company that develops,
 manufactures and markets Active Pharmaceutical Ingredients (APIs),
 Intermediate Chemicals and Finished Dosage Forms.

 WE MAKE THE CHEMISTRY WORK.




www.heteroeurope.com

                                                          www.heteroeurope.com
THE CHEMISTRY OF BEING WORLD CLASS - A TRADITION OF EXCELLENCE




              Established in 1993
              High standards and adherence to worldwide regulatory guidelines
              All 18 manufacturing facilities comply with cGMP and global
              standards for infrastructure and systems
              High approval by internationally recognised regulatory such as
              USFDA, WHO, TGA (Australia), ANVISA (Brazil), and several
              European agencies




www.heteroeurope.com

                                                                                www.heteroeurope.com
THE CHEMISTRY OF BEING WORLD CLASS
 WORLDWIDE, FIRST-CLASS FACILITIES


                       6000 employees across the globe
                       Full-scale marketing resources across entire
                       network
                       Products marketed (directly or through partners) to
                       more than 100 countries




www.heteroeurope.com

                                                                   www.heteroeurope.com
THE CHEMISTRY OF BEING WORLD CLASS - WORLDWIDE, FIRST-CLASS FACILITIES



    Continually invest in manufacturing facilities and capabilities
    Recently inaugurated one of India’s largest finished dosage manufacturing facilities

              75 acres, 2 manufacturing plants, annual production capacity of 18 billion tablets
              and capsules, dedicated oncology facility
              Meets cGMP and regulatory requirements, integrated quality management
              system, 21-CFR compliant
              State-of-art product equipment including walk-in type stability chambers,
              Honeywell integrated building management system, VirTis Lyophilizer, BOSCH
              Liquid Filling Machine




www.heteroeurope.com

                                                                                            www.heteroeurope.com
THE CHEMISTRY OF COMPLETE SOLUTIONS - ACTIVE PHARMACEUTICAL INGREDIENTS (APIs)

          One of the largest leading manufacturers and suppliers of APIs and
          intermediate chemicals
          First-class manufacturing infrastructure, 11 API facilities in operation:
                  fully equipped and state-of-the art, meeting global standards and cGMPs
                  produce and supply more than 200 APIs to different countries
                  6 facilities approved by USFDA, TGA, EU and WHO
          Wide range of therapuetic categories
          Largest supplier of a complete range of antiretroviral products




www.heteroeurope.com

                                                                                            www.heteroeurope.com
THE CHEMISTRY OF COMPLETE SOLUTIONS - FINISHED DOSAGE FORMS

   First-class facilities for manufacturing a wide range of finished dosage forms
   Significant numbers of new products added every year
   4 finished dosage manufacturing facilities and a dedicated oncology facility offer:
                       sterile dosage forms, pre-filled syringes,
                       solid and liquid oral dosage forms,
                       ointments, soft-gelatine capsules and inhalers




www.heteroeurope.com

                                                                                         www.heteroeurope.com
THE CHEMISTRY OF BEING WORLD CLASS - A COMPETITIVE, FULL SERVICE OFFERING




       Competitive manufacture at all stages in state-of-the art facilities in India
       Products released from European headquarters in Barcelona, where we offer
       local services such as:

                       licensing eCTD-dossiers
                       full regulatory support with European submissions-national, MRP or
                       DCP
                       supply of the finished dosage forms




www.heteroeurope.com

                                                                                            www.heteroeurope.com
AT HETERO,

 our aim is simple - to maintain our position as one of
 the world’s leading suppliers of high-quality, easily accessible and
 affordable drugs. The global need for cost-effective medicinal
 products is greater than ever. In working towards our aim we take
 pride in being one of the manufacturers truly making a difference. We
 will make the chemistry work.

 THE CHEMISTRY OF REALISING DREAMS.



www.heteroeurope.com

                                                            www.heteroeurope.com
1.     We have breadth and depth
          Strong R&D
          Rich portfolio and pipeline of products
          Conventional generic drugs       specialised therapeutic areas (e.g. oncology and anti-HIV)



2.     We are cost          effective
         Competitive Indian manufacturing
         Full vertical integration
         High quality, affordable drugs


3.     We are local
         European HQ in Barcelona
         Proximity to develop strong and productive client relationships


4.     We care
         Privately owned company with strong sense of social responsibility
         High standards, worldwide regulatory approvals
         Discovering new or improved drugs in areas like HIV, HCV and diabetes


www.heteroeurope.com

                                                                                             www.heteroeurope.com
THANK YOU
 CONTACT US




  Viladecans Business Park - Edificio Brasil
  Catalunya 83-85 - 08440 Viladecans
  Barcelona - Spain
  Tel. +34 93 647 60 70
  info@heteroeurope.com



www.heteroeurope.com

                                               www.heteroeurope.com

Mais conteúdo relacionado

Mais procurados

Roadmap to reimbursement and access
Roadmap to reimbursement and accessRoadmap to reimbursement and access
Roadmap to reimbursement and accessRhonda Greenapple
 
Pharmaceutical Pricing and Market Access
Pharmaceutical Pricing and Market AccessPharmaceutical Pricing and Market Access
Pharmaceutical Pricing and Market AccessTeri Arri
 
Case studies in Strategy: Teva
Case studies in Strategy: TevaCase studies in Strategy: Teva
Case studies in Strategy: TevaDan Saguy
 
Future Pharma Trends - Long-term opportunities tempered by short-term challenges
Future Pharma Trends - Long-term opportunities tempered by short-term challengesFuture Pharma Trends - Long-term opportunities tempered by short-term challenges
Future Pharma Trends - Long-term opportunities tempered by short-term challengesscottosur
 
Business Plan on a Bio-Tech product
Business Plan on a Bio-Tech productBusiness Plan on a Bio-Tech product
Business Plan on a Bio-Tech productTarkeshwar Singh
 
Early asset development and commercialization: Partnering for success
Early asset development and commercialization: Partnering for successEarly asset development and commercialization: Partnering for success
Early asset development and commercialization: Partnering for successCello Health
 
Pharma Product Lifecycle Management and Brand Defense Strategy: Tips
Pharma Product Lifecycle Management and Brand Defense Strategy: TipsPharma Product Lifecycle Management and Brand Defense Strategy: Tips
Pharma Product Lifecycle Management and Brand Defense Strategy: TipsGünter Umbach, MD
 
Problems facing the pharmaceutical industry
Problems facing the pharmaceutical industryProblems facing the pharmaceutical industry
Problems facing the pharmaceutical industryKelly To
 
Rapport biosimilars excerpts
Rapport biosimilars excerptsRapport biosimilars excerpts
Rapport biosimilars excerptsJean-Michel Peny
 
Market Access, Pricing and Reimbursement streamlined
Market Access, Pricing and Reimbursement streamlinedMarket Access, Pricing and Reimbursement streamlined
Market Access, Pricing and Reimbursement streamlinedWang-yee Liu
 
Strategic Analysis - Sanofi Aventis
Strategic Analysis - Sanofi AventisStrategic Analysis - Sanofi Aventis
Strategic Analysis - Sanofi AventisBruno Rakotozafy
 
Oncology biosimilars Market Report in PPT: Top Companies, Trends and Future D...
Oncology biosimilars Market Report in PPT: Top Companies, Trends and Future D...Oncology biosimilars Market Report in PPT: Top Companies, Trends and Future D...
Oncology biosimilars Market Report in PPT: Top Companies, Trends and Future D...IMARC Group
 
French generics market attractiveness 2017 - 2022 excerpt
French generics market attractiveness   2017 - 2022 excerptFrench generics market attractiveness   2017 - 2022 excerpt
French generics market attractiveness 2017 - 2022 excerptJean-Michel Peny
 
Teva Pharmaceuticals
Teva PharmaceuticalsTeva Pharmaceuticals
Teva PharmaceuticalsCJ_Wei
 
Business plan south africa ravi
Business plan south africa raviBusiness plan south africa ravi
Business plan south africa raviRavi Nishankar
 
Corporate Strategy Assignment - The Global Pharmaceutical Industry
Corporate Strategy Assignment - The Global Pharmaceutical IndustryCorporate Strategy Assignment - The Global Pharmaceutical Industry
Corporate Strategy Assignment - The Global Pharmaceutical IndustryAmany Hamza
 
Best in-class Key Account Managers
Best in-class Key Account ManagersBest in-class Key Account Managers
Best in-class Key Account ManagersJean-Michel Peny
 
Best in-class Medical Science Liasons
Best in-class Medical Science LiasonsBest in-class Medical Science Liasons
Best in-class Medical Science LiasonsJean-Michel Peny
 
Quick Start - Your partner for pharmaceutical and medical marketing in Ukraine
Quick Start - Your partner for pharmaceutical and medical marketing in Ukraine Quick Start - Your partner for pharmaceutical and medical marketing in Ukraine
Quick Start - Your partner for pharmaceutical and medical marketing in Ukraine Sergei Shevchenko
 

Mais procurados (20)

Healthcare, Medical and Pharmaceutical Market Access Strategies - John Baresk...
Healthcare, Medical and Pharmaceutical Market Access Strategies - John Baresk...Healthcare, Medical and Pharmaceutical Market Access Strategies - John Baresk...
Healthcare, Medical and Pharmaceutical Market Access Strategies - John Baresk...
 
Roadmap to reimbursement and access
Roadmap to reimbursement and accessRoadmap to reimbursement and access
Roadmap to reimbursement and access
 
Pharmaceutical Pricing and Market Access
Pharmaceutical Pricing and Market AccessPharmaceutical Pricing and Market Access
Pharmaceutical Pricing and Market Access
 
Case studies in Strategy: Teva
Case studies in Strategy: TevaCase studies in Strategy: Teva
Case studies in Strategy: Teva
 
Future Pharma Trends - Long-term opportunities tempered by short-term challenges
Future Pharma Trends - Long-term opportunities tempered by short-term challengesFuture Pharma Trends - Long-term opportunities tempered by short-term challenges
Future Pharma Trends - Long-term opportunities tempered by short-term challenges
 
Business Plan on a Bio-Tech product
Business Plan on a Bio-Tech productBusiness Plan on a Bio-Tech product
Business Plan on a Bio-Tech product
 
Early asset development and commercialization: Partnering for success
Early asset development and commercialization: Partnering for successEarly asset development and commercialization: Partnering for success
Early asset development and commercialization: Partnering for success
 
Pharma Product Lifecycle Management and Brand Defense Strategy: Tips
Pharma Product Lifecycle Management and Brand Defense Strategy: TipsPharma Product Lifecycle Management and Brand Defense Strategy: Tips
Pharma Product Lifecycle Management and Brand Defense Strategy: Tips
 
Problems facing the pharmaceutical industry
Problems facing the pharmaceutical industryProblems facing the pharmaceutical industry
Problems facing the pharmaceutical industry
 
Rapport biosimilars excerpts
Rapport biosimilars excerptsRapport biosimilars excerpts
Rapport biosimilars excerpts
 
Market Access, Pricing and Reimbursement streamlined
Market Access, Pricing and Reimbursement streamlinedMarket Access, Pricing and Reimbursement streamlined
Market Access, Pricing and Reimbursement streamlined
 
Strategic Analysis - Sanofi Aventis
Strategic Analysis - Sanofi AventisStrategic Analysis - Sanofi Aventis
Strategic Analysis - Sanofi Aventis
 
Oncology biosimilars Market Report in PPT: Top Companies, Trends and Future D...
Oncology biosimilars Market Report in PPT: Top Companies, Trends and Future D...Oncology biosimilars Market Report in PPT: Top Companies, Trends and Future D...
Oncology biosimilars Market Report in PPT: Top Companies, Trends and Future D...
 
French generics market attractiveness 2017 - 2022 excerpt
French generics market attractiveness   2017 - 2022 excerptFrench generics market attractiveness   2017 - 2022 excerpt
French generics market attractiveness 2017 - 2022 excerpt
 
Teva Pharmaceuticals
Teva PharmaceuticalsTeva Pharmaceuticals
Teva Pharmaceuticals
 
Business plan south africa ravi
Business plan south africa raviBusiness plan south africa ravi
Business plan south africa ravi
 
Corporate Strategy Assignment - The Global Pharmaceutical Industry
Corporate Strategy Assignment - The Global Pharmaceutical IndustryCorporate Strategy Assignment - The Global Pharmaceutical Industry
Corporate Strategy Assignment - The Global Pharmaceutical Industry
 
Best in-class Key Account Managers
Best in-class Key Account ManagersBest in-class Key Account Managers
Best in-class Key Account Managers
 
Best in-class Medical Science Liasons
Best in-class Medical Science LiasonsBest in-class Medical Science Liasons
Best in-class Medical Science Liasons
 
Quick Start - Your partner for pharmaceutical and medical marketing in Ukraine
Quick Start - Your partner for pharmaceutical and medical marketing in Ukraine Quick Start - Your partner for pharmaceutical and medical marketing in Ukraine
Quick Start - Your partner for pharmaceutical and medical marketing in Ukraine
 

Semelhante a Hetero Europe company presentation 2010

Vetro, the vector of change in the veterinary market from Romania.
Vetro, the vector of change in the veterinary market from Romania.Vetro, the vector of change in the veterinary market from Romania.
Vetro, the vector of change in the veterinary market from Romania.VladFluturel
 
LGM Pharma | Drug Research & Development APIs
LGM Pharma | Drug Research & Development APIsLGM Pharma | Drug Research & Development APIs
LGM Pharma | Drug Research & Development APIsLGM Pharma
 
Herbion Coporate Presentation
Herbion Coporate PresentationHerbion Coporate Presentation
Herbion Coporate PresentationRana Nouman
 
HECHT Brochure Food (BeNeLux) high end food
HECHT  Brochure Food (BeNeLux) high end foodHECHT  Brochure Food (BeNeLux) high end food
HECHT Brochure Food (BeNeLux) high end foodhttps://plantpartner.nl/
 
HECHT Brochure Food (BeNeLux) high end food
HECHT  Brochure Food (BeNeLux) high end foodHECHT  Brochure Food (BeNeLux) high end food
HECHT Brochure Food (BeNeLux) high end foodhttps://plantpartner.nl/
 
Domainex Hypha Press Release
Domainex Hypha Press ReleaseDomainex Hypha Press Release
Domainex Hypha Press Releasepfallon
 
A better way to feed the planet
A better way to feed the planetA better way to feed the planet
A better way to feed the planetAlain Lesage
 
4th Pre Filled Syringes (2011) Pp
4th Pre Filled Syringes (2011) Pp4th Pre Filled Syringes (2011) Pp
4th Pre Filled Syringes (2011) PpPiyush Patel
 
2016-11-28 Mentlife seminar: Pharmaceutical Drug Development; An Overall Pers...
2016-11-28 Mentlife seminar: Pharmaceutical Drug Development; An Overall Pers...2016-11-28 Mentlife seminar: Pharmaceutical Drug Development; An Overall Pers...
2016-11-28 Mentlife seminar: Pharmaceutical Drug Development; An Overall Pers...MentLife
 
International marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIXInternational marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIXDhanushka Bandara
 
Apresentação cipan sbe ist_2016_4(post link_in)
Apresentação cipan sbe ist_2016_4(post link_in)Apresentação cipan sbe ist_2016_4(post link_in)
Apresentação cipan sbe ist_2016_4(post link_in)Manuel Eduardo Fernandes
 
Presentation-French-clusters-Adebiotech-BMsystems-manuel-gea09052016-vonline
Presentation-French-clusters-Adebiotech-BMsystems-manuel-gea09052016-vonlinePresentation-French-clusters-Adebiotech-BMsystems-manuel-gea09052016-vonline
Presentation-French-clusters-Adebiotech-BMsystems-manuel-gea09052016-vonlineManuel GEA - Bio-Modeling Systems
 
Single Use Bioreactors (2012)
Single Use Bioreactors (2012)Single Use Bioreactors (2012)
Single Use Bioreactors (2012)shad121
 
NARCOTIC ANAGETIC DRUG AHMEDABAD
NARCOTIC ANAGETIC DRUG AHMEDABADNARCOTIC ANAGETIC DRUG AHMEDABAD
NARCOTIC ANAGETIC DRUG AHMEDABADjitharadharmesh
 
Schwitz Biotech, Ahmedabad, Pharmaceutical Formulations
Schwitz Biotech, Ahmedabad, Pharmaceutical FormulationsSchwitz Biotech, Ahmedabad, Pharmaceutical Formulations
Schwitz Biotech, Ahmedabad, Pharmaceutical FormulationsIndiaMART InterMESH Limited
 
Kemwell biologics presentation bp April 2018
Kemwell biologics presentation bp April 2018Kemwell biologics presentation bp April 2018
Kemwell biologics presentation bp April 2018MithaliRosario
 

Semelhante a Hetero Europe company presentation 2010 (20)

Vetro, the vector of change in the veterinary market from Romania.
Vetro, the vector of change in the veterinary market from Romania.Vetro, the vector of change in the veterinary market from Romania.
Vetro, the vector of change in the veterinary market from Romania.
 
LGM Pharma | Drug Research & Development APIs
LGM Pharma | Drug Research & Development APIsLGM Pharma | Drug Research & Development APIs
LGM Pharma | Drug Research & Development APIs
 
Herbion Coporate Presentation
Herbion Coporate PresentationHerbion Coporate Presentation
Herbion Coporate Presentation
 
HECHT Brochure Food (BeNeLux) high end food
HECHT  Brochure Food (BeNeLux) high end foodHECHT  Brochure Food (BeNeLux) high end food
HECHT Brochure Food (BeNeLux) high end food
 
HECHT Brochure Food (BeNeLux) high end food
HECHT  Brochure Food (BeNeLux) high end foodHECHT  Brochure Food (BeNeLux) high end food
HECHT Brochure Food (BeNeLux) high end food
 
Corp Overview
Corp OverviewCorp Overview
Corp Overview
 
Bhavna final
Bhavna finalBhavna final
Bhavna final
 
Domainex Hypha Press Release
Domainex Hypha Press ReleaseDomainex Hypha Press Release
Domainex Hypha Press Release
 
A better way to feed the planet
A better way to feed the planetA better way to feed the planet
A better way to feed the planet
 
4th Pre Filled Syringes (2011) Pp
4th Pre Filled Syringes (2011) Pp4th Pre Filled Syringes (2011) Pp
4th Pre Filled Syringes (2011) Pp
 
2016-11-28 Mentlife seminar: Pharmaceutical Drug Development; An Overall Pers...
2016-11-28 Mentlife seminar: Pharmaceutical Drug Development; An Overall Pers...2016-11-28 Mentlife seminar: Pharmaceutical Drug Development; An Overall Pers...
2016-11-28 Mentlife seminar: Pharmaceutical Drug Development; An Overall Pers...
 
International marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIXInternational marketing Marketing Decisions on marketing MIX
International marketing Marketing Decisions on marketing MIX
 
Apresentação cipan sbe ist_2016_4(post link_in)
Apresentação cipan sbe ist_2016_4(post link_in)Apresentação cipan sbe ist_2016_4(post link_in)
Apresentação cipan sbe ist_2016_4(post link_in)
 
Presentation-French-clusters-Adebiotech-BMsystems-manuel-gea09052016-vonline
Presentation-French-clusters-Adebiotech-BMsystems-manuel-gea09052016-vonlinePresentation-French-clusters-Adebiotech-BMsystems-manuel-gea09052016-vonline
Presentation-French-clusters-Adebiotech-BMsystems-manuel-gea09052016-vonline
 
Single Use Bioreactors (2012)
Single Use Bioreactors (2012)Single Use Bioreactors (2012)
Single Use Bioreactors (2012)
 
NARCOTIC ANAGETIC DRUG AHMEDABAD
NARCOTIC ANAGETIC DRUG AHMEDABADNARCOTIC ANAGETIC DRUG AHMEDABAD
NARCOTIC ANAGETIC DRUG AHMEDABAD
 
Revive Brochure
Revive BrochureRevive Brochure
Revive Brochure
 
PharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing ServicesPharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing Services
 
Schwitz Biotech, Ahmedabad, Pharmaceutical Formulations
Schwitz Biotech, Ahmedabad, Pharmaceutical FormulationsSchwitz Biotech, Ahmedabad, Pharmaceutical Formulations
Schwitz Biotech, Ahmedabad, Pharmaceutical Formulations
 
Kemwell biologics presentation bp April 2018
Kemwell biologics presentation bp April 2018Kemwell biologics presentation bp April 2018
Kemwell biologics presentation bp April 2018
 

Mais de Generic Pharma 2.0

Mais de Generic Pharma 2.0 (20)

WSGR Alert
WSGR AlertWSGR Alert
WSGR Alert
 
WSGR Alert
WSGR AlertWSGR Alert
WSGR Alert
 
WSGR Alert
WSGR AlertWSGR Alert
WSGR Alert
 
New Pharma Magazine Launch Party in NYC!
New Pharma Magazine Launch Party in NYC! New Pharma Magazine Launch Party in NYC!
New Pharma Magazine Launch Party in NYC!
 
Cheryl investigates
Cheryl investigatesCheryl investigates
Cheryl investigates
 
GP20 Licensing Pavillion 2012 Coexhibitor Kit
GP20 Licensing Pavillion 2012 Coexhibitor KitGP20 Licensing Pavillion 2012 Coexhibitor Kit
GP20 Licensing Pavillion 2012 Coexhibitor Kit
 
BioSimilar Drug Development World
BioSimilar Drug Development WorldBioSimilar Drug Development World
BioSimilar Drug Development World
 
Your Ideal Pfizer
Your Ideal PfizerYour Ideal Pfizer
Your Ideal Pfizer
 
Animal health
Animal healthAnimal health
Animal health
 
Moving @ the Speed of Social
Moving @ the Speed of SocialMoving @ the Speed of Social
Moving @ the Speed of Social
 
New Pharma Magazine Seeking Contributors
New Pharma Magazine Seeking ContributorsNew Pharma Magazine Seeking Contributors
New Pharma Magazine Seeking Contributors
 
OTC Licensing Product Portfolio
OTC Licensing Product PortfolioOTC Licensing Product Portfolio
OTC Licensing Product Portfolio
 
LinkedIn Survey Results
LinkedIn Survey ResultsLinkedIn Survey Results
LinkedIn Survey Results
 
CPHI 2012! Generic Pharma 2.0 Stand Design
CPHI 2012! Generic Pharma 2.0 Stand DesignCPHI 2012! Generic Pharma 2.0 Stand Design
CPHI 2012! Generic Pharma 2.0 Stand Design
 
GL infographics
GL infographicsGL infographics
GL infographics
 
New Pharma Magazine
New Pharma MagazineNew Pharma Magazine
New Pharma Magazine
 
Woerwag RD presentation
Woerwag RD presentationWoerwag RD presentation
Woerwag RD presentation
 
Neogen presentation april_2011_gl
Neogen presentation april_2011_glNeogen presentation april_2011_gl
Neogen presentation april_2011_gl
 
Genericlicensing.com - featured companies 2011
Genericlicensing.com - featured companies 2011Genericlicensing.com - featured companies 2011
Genericlicensing.com - featured companies 2011
 
2011 Global Generic Product Directory Demo
2011 Global Generic Product Directory Demo2011 Global Generic Product Directory Demo
2011 Global Generic Product Directory Demo
 

Hetero Europe company presentation 2010

  • 1.
  • 2. WE ARE HETERO, a research-based, global pharmaceutical company that develops, manufactures and markets Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals and Finished Dosage Forms. WE MAKE THE CHEMISTRY WORK. www.heteroeurope.com www.heteroeurope.com
  • 3. THE CHEMISTRY OF BEING WORLD CLASS - A TRADITION OF EXCELLENCE Established in 1993 High standards and adherence to worldwide regulatory guidelines All 18 manufacturing facilities comply with cGMP and global standards for infrastructure and systems High approval by internationally recognised regulatory such as USFDA, WHO, TGA (Australia), ANVISA (Brazil), and several European agencies www.heteroeurope.com www.heteroeurope.com
  • 4. THE CHEMISTRY OF BEING WORLD CLASS WORLDWIDE, FIRST-CLASS FACILITIES 6000 employees across the globe Full-scale marketing resources across entire network Products marketed (directly or through partners) to more than 100 countries www.heteroeurope.com www.heteroeurope.com
  • 5. THE CHEMISTRY OF BEING WORLD CLASS - WORLDWIDE, FIRST-CLASS FACILITIES Continually invest in manufacturing facilities and capabilities Recently inaugurated one of India’s largest finished dosage manufacturing facilities 75 acres, 2 manufacturing plants, annual production capacity of 18 billion tablets and capsules, dedicated oncology facility Meets cGMP and regulatory requirements, integrated quality management system, 21-CFR compliant State-of-art product equipment including walk-in type stability chambers, Honeywell integrated building management system, VirTis Lyophilizer, BOSCH Liquid Filling Machine www.heteroeurope.com www.heteroeurope.com
  • 6. THE CHEMISTRY OF COMPLETE SOLUTIONS - ACTIVE PHARMACEUTICAL INGREDIENTS (APIs) One of the largest leading manufacturers and suppliers of APIs and intermediate chemicals First-class manufacturing infrastructure, 11 API facilities in operation: fully equipped and state-of-the art, meeting global standards and cGMPs produce and supply more than 200 APIs to different countries 6 facilities approved by USFDA, TGA, EU and WHO Wide range of therapuetic categories Largest supplier of a complete range of antiretroviral products www.heteroeurope.com www.heteroeurope.com
  • 7. THE CHEMISTRY OF COMPLETE SOLUTIONS - FINISHED DOSAGE FORMS First-class facilities for manufacturing a wide range of finished dosage forms Significant numbers of new products added every year 4 finished dosage manufacturing facilities and a dedicated oncology facility offer: sterile dosage forms, pre-filled syringes, solid and liquid oral dosage forms, ointments, soft-gelatine capsules and inhalers www.heteroeurope.com www.heteroeurope.com
  • 8. THE CHEMISTRY OF BEING WORLD CLASS - A COMPETITIVE, FULL SERVICE OFFERING Competitive manufacture at all stages in state-of-the art facilities in India Products released from European headquarters in Barcelona, where we offer local services such as: licensing eCTD-dossiers full regulatory support with European submissions-national, MRP or DCP supply of the finished dosage forms www.heteroeurope.com www.heteroeurope.com
  • 9. AT HETERO, our aim is simple - to maintain our position as one of the world’s leading suppliers of high-quality, easily accessible and affordable drugs. The global need for cost-effective medicinal products is greater than ever. In working towards our aim we take pride in being one of the manufacturers truly making a difference. We will make the chemistry work. THE CHEMISTRY OF REALISING DREAMS. www.heteroeurope.com www.heteroeurope.com
  • 10. 1. We have breadth and depth Strong R&D Rich portfolio and pipeline of products Conventional generic drugs specialised therapeutic areas (e.g. oncology and anti-HIV) 2. We are cost effective Competitive Indian manufacturing Full vertical integration High quality, affordable drugs 3. We are local European HQ in Barcelona Proximity to develop strong and productive client relationships 4. We care Privately owned company with strong sense of social responsibility High standards, worldwide regulatory approvals Discovering new or improved drugs in areas like HIV, HCV and diabetes www.heteroeurope.com www.heteroeurope.com
  • 11. THANK YOU CONTACT US Viladecans Business Park - Edificio Brasil Catalunya 83-85 - 08440 Viladecans Barcelona - Spain Tel. +34 93 647 60 70 info@heteroeurope.com www.heteroeurope.com www.heteroeurope.com